TOBRAMYCIN for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 386 adverse event reports in the FDA FAERS database where TOBRAMYCIN was used for Off label use.
Most Reported Side Effects for TOBRAMYCIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 1,467 | 12.7% | 158 | 489 |
| Death | 888 | 7.7% | 880 | 50 |
| Cough | 738 | 6.4% | 18 | 260 |
| Dyspnoea | 706 | 6.1% | 22 | 367 |
| Pneumonia | 700 | 6.0% | 43 | 578 |
| Hospitalisation | 688 | 5.9% | 5 | 601 |
| Condition aggravated | 669 | 5.8% | 43 | 439 |
| Cystic fibrosis | 646 | 5.6% | 49 | 520 |
| Infective pulmonary exacerbation of cystic fibrosis | 504 | 4.4% | 16 | 435 |
| Drug ineffective | 453 | 3.9% | 104 | 174 |
| Acute kidney injury | 372 | 3.2% | 32 | 230 |
| Malaise | 361 | 3.1% | 12 | 165 |
| Ill-defined disorder | 344 | 3.0% | 4 | 315 |
| Product use issue | 338 | 2.9% | 52 | 77 |
| Infection | 289 | 2.5% | 16 | 200 |
Other Indications for TOBRAMYCIN
Cystic fibrosis (4,219)
Product used for unknown indication (2,332)
Pseudomonas infection (984)
Bronchiectasis (977)
Lung disorder (280)
Cystic fibrosis lung (212)
Pneumonia pseudomonal (170)
Chronic obstructive pulmonary disease (151)
Infective pulmonary exacerbation of cystic fibrosis (144)
Pneumonia (135)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)